Cancer/Tumor Profiling Market by Technique, by Technology and by Application - Global Opportunity Analysis and Industry Forecast 2022-2030

12980
Present Value (M$)
2022
31670
Forecast Value (M$)
2030
11.8%
CAGR (%)

The Cancer/Tumor Profiling Market size was valued at USD 12.98 billion in 2022 and is predicted to reach USD 31.67 billion by 2030 with a CAGR of 11.8% from 2022-2030.

Main companies

  • Lucence Health Inc.
  • F. Hoffmann-La Roche Ltd
  • Caris Life Sciences
  • ACT Genomics Co.
  • LTD
  • Thermo Fisher Scientific Inc.
  • Strand Life Sciences
  • IMB Dx
  • Inc.
  • Illumina
  • Inc.
  • Guardant Health
  • QIAGEN
  • Ribomed Biotechnologies Inc.
  • HTG Molecular Diagnostics
  • Inc.
  • NanoString
  • NeoGenomics Laboratories
  • Exact Sciences Corporation